229 related articles for article (PubMed ID: 30482592)
1. In search of: Suggesting a course of action for the scientific community to research potential impacts of heritable gene editing on the maternal carrier.
Gravelle R
Semin Perinatol; 2018 Dec; 42(8):522-524. PubMed ID: 30482592
[TBL] [Abstract][Full Text] [Related]
2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
3. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
4. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
Kofler N; Kraschel KL
Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
[TBL] [Abstract][Full Text] [Related]
5. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
6. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
7. A new era of gene editing for the treatment of human diseases.
Kc M; Steer CJ
Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
[TBL] [Abstract][Full Text] [Related]
8. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
10. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
[TBL] [Abstract][Full Text] [Related]
11. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
Grant EV
Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
Musunuru K
J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
[TBL] [Abstract][Full Text] [Related]
13. Gene editing in human development: ethical concerns and practical applications.
Rossant J
Development; 2018 Jul; 145(16):. PubMed ID: 30045910
[TBL] [Abstract][Full Text] [Related]
14. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC; Musunuru K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
[TBL] [Abstract][Full Text] [Related]
16. CRISPR editing in biological and biomedical investigation.
Huang J; Wang Y; Zhao J
J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
[TBL] [Abstract][Full Text] [Related]
17. Ethics of Human Genome Editing.
Coller BS
Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
19. Off- and on-target effects of genome editing in mouse embryos.
Ayabe S; Nakashima K; Yoshiki A
J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
[TBL] [Abstract][Full Text] [Related]
20. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
Burbery R
J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]